Bioabsorbable Stents Market Size, Share, Industry Trends and Report 2033

Global Bioabsorbable Stents Industry: Key Statistics and Insights in 2025-2033

Summary:

    • The market is expected to reach USD 786.5 Million by 2033, exhibiting a growth rate (CAGR) of 6.72% during 2025-2033.

    • North America leads the market, accounting for the largest bioabsorbable stents market share.

    • Most of the market share in the biomaterial segment belongs to polymer-based bioabsorbable stents.

    • The largest share of the bioabsorbable stents industry belongs to slow-absorption stents.

    • Coronary artery disease holds the largest market share due to its high prevalence, which creates a strong demand for advanced treatments such as bioabsorbable stents.

    • Hospitals make up the largest end-user segment. The rising number of cardiovascular diseases is driving the demand for bioabsorbable stents.

    • Advances in stent technology and a growing awareness of less invasive procedures are changing the market for bioabsorbable stents.

Bioabsorbable Stents Market Size

Industry Trends and Drivers:

    • Increasing prevalence of cardiovascular diseases:

With heart disease as a leading cause of death worldwide, there is a high need for advanced treatment options. Traditional metal stents are effective but carry risks like long-term inflammation, thrombosis, and restenosis. Bioabsorbable stents provide a modern alternative by offering the support needed to reopen blocked arteries while gradually dissolving over time. This minimizes the risks of permanent implants. This feature appeals to both patients and healthcare providers who want safer, less invasive treatment solutions. The rising cases of heart disease, fueled by aging populations, sedentary lifestyles, and unhealthy diets, are driving demand for bioabsorbable stents.

    • Advancements in stent technology:

Manufacturers are investing in research and development to create next-generation bioabsorbable stents that outperform earlier models. These improvements include better flexibility, durability, and drug-eluting capabilities, which aim to enhance arterial support and reduce complications like restenosis and thrombosis. Newer bioabsorbable stents are made from biodegradable materials that dissolve naturally within the body after maintaining blood flow. This eliminates the need for permanent implants and lowers the risk of long-term complications. Also, faster-absorbing and more effective stents are increasing healthcare providers' confidence in recommending them.

    • Growing awareness and preference for minimally invasive procedures:

Patients and healthcare providers are becoming more informed about the benefits of minimally invasive procedures, leading to the adoption of bioabsorbable stents. Unlike traditional metal stents, bioabsorbable stents enable quicker recovery, less scarring, and a lower risk of long-term complications. These benefits attract patients seeking safer, less intrusive treatment options. Healthcare systems are also focusing on cost-effective treatments that cut the need for repeat interventions, long hospital stays, or extensive follow-up care. Bioabsorbable stents gradually dissolve after the artery heals, reducing further complications and making them a favored choice for doctors and patients.

Request for a sample copy of this report: https://www.imarcgroup.com/bioabsorbable-stents-market/requestsample

Bioabsorbable Stents Market Report Segmentation:

Breakup By Biomaterial:

Bioabsorbable Stents Market

    • Polymer-based Bioabsorbable Stents

    • Metal-based Bioabsorbable Stents

Polymer-based bioabsorbable stents exhibit a clear dominance in the market accredited to their superior flexibility and biocompatibility, which minimize the risk of arterial irritation and promote better healing.

Breakup By Absorption Rate:

    • Slow-Absorption Stents

    • Fast-Absorption Stents

Slow-absorption stents represent the largest segment, as they provide prolonged support to the artery, reducing the likelihood of vessel recoil and late thrombosis.

Breakup By Region:

    • North America (United States, Canada)

    • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

    • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

    • Latin America (Brazil, Mexico, Others)

    • Middle East and Africa

North America dominates the market owing to the existence of an advanced healthcare infrastructure and the presence of leading device manufacturers in the region.

Top Bioabsorbable Stents Market Leaders:

The bioabsorbable stents market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

Bioabsorbable Stents Market

    • Abbott Laboratories

    • Arterius Limited

    • B. Braun SE

    • Biotronik SE & Co. KG

    • Boston Scientific Corporation

    • Elixir Medical Corporation

    • Kyoto Medical Planning Co. Ltd.

    • Lepu Medical Technology (Beijing) Co. Ltd.

    • Meril Life Sciences Pvt. Ltd.

    • Reva Medical LLC

    • Terumo Corporation

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145